Penn Medicine – The Intersection of Hypertension, Diabetes, and Lipids: Everything You Need to Know in Preventive Cardiology in 2021

Advanced Preventive Cardiology, Hypertension, Diabetes & Lipid Management Update

Overview

The Penn Medicine The Intersection of Hypertension, Diabetes, and Lipids: Everything You Need to Know in Preventive Cardiology in 2021 course provides a comprehensive review of contemporary preventive cardiology, focusing on the interconnected management of hypertension, diabetes, dyslipidemia, chronic kidney disease, and cardiovascular risk reduction.

Held virtually on October 1, 2021, this evidence-based program highlights recent advances in cardiovascular prevention and explores how emerging pharmacologic therapies can reduce cardiovascular events, slow kidney disease progression, and improve long-term outcomes in high-risk patients.

The curriculum emphasizes practical implementation of modern preventive cardiology strategies, including the use of SGLT2 inhibitors, GLP-1 receptor agonists, hypertension management, lipid optimization, and cardiovascular risk assessment.

Course Features

• 13 Video Lectures
• 12 PDF Presentations
• Total Size: 4.86 GB
• Expert Penn Medicine Faculty
• Evidence-Based Preventive Cardiology Updates
• Hypertension Management Reviews
• Diabetes & Cardiovascular Disease Education
• Lipid Management Strategies
• Chronic Kidney Disease Risk Reduction
• Contemporary Pharmacotherapy Updates

Target Audience

This course is ideal for:

Physicians

• Cardiologists
• Preventive Cardiologists
• Internal Medicine Physicians
• Family Medicine Physicians
• Endocrinologists
• Nephrologists
• Sports Medicine Physicians
• Obstetric & Maternal-Fetal Medicine Specialists
• Heart Failure Specialists
• Electrophysiologists
• Interventional Cardiologists

Healthcare Professionals

• Nurse Practitioners
• Physician Assistants
• Pharmacists
• Public Health Professionals
• Clinical Informatics Specialists
• Medical Trainees

Learning Objectives

Upon completion of this activity, participants will be able to:

• Select therapies that reduce cardiovascular events in high-risk populations.
• Apply contemporary blood pressure targets in special patient populations.
• Evaluate screening and management strategies for primary aldosteronism.
• Optimize hypertension treatment in patients with dyslipidemia.
• Integrate pharmacologic and lifestyle interventions for cardiovascular prevention.
• Utilize SGLT2 inhibitors and GLP-1 receptor agonists appropriately.
• Improve cardiovascular and renal outcomes in patients with diabetes.
• Apply evidence-based preventive cardiology strategies in clinical practice.

Core Scientific Topics

Preventive Cardiology

The primary focus of the course is comprehensive cardiovascular risk reduction.

Topics Include

• Primary Prevention
• Secondary Prevention
• Risk Stratification
• ASCVD Prevention
• Cardiometabolic Risk Reduction
• Lifestyle Interventions

Faculty review practical approaches for reducing long-term cardiovascular morbidity and mortality.

Hypertension Management

A major component of the program focuses on blood pressure control.

Covered Areas

• Contemporary Hypertension Guidelines
• Blood Pressure Targets
• Resistant Hypertension
• Special Populations
• Hypertension Monitoring
• Treatment Optimization

Participants review evidence-based approaches to individualized blood pressure management.

Primary Aldosteronism

Dedicated sessions examine one of the most commonly underdiagnosed causes of secondary hypertension.

Topics Include

• Screening Indications
• Diagnostic Testing
• Confirmatory Evaluation
• Treatment Options
• Surgical vs Medical Therapy
• Controversies in Management

Diabetes & Cardiovascular Disease

The course highlights the evolving relationship between diabetes therapies and cardiovascular outcomes.

Topics Include

• Cardiovascular Risk in Diabetes
• Glycemic Management
• Cardiometabolic Disease
• Renal Protection
• Heart Failure Prevention
• Outcome Trials

SGLT2 Inhibitors

Extensive review is provided on this rapidly evolving therapeutic class.

Covered Areas

• Cardiovascular Benefits
• Heart Failure Risk Reduction
• Kidney Protection
• Clinical Trial Evidence
• Patient Selection
• Practical Prescribing Strategies

Faculty discuss integration of SGLT2 inhibitors into modern cardiovascular care pathways.

GLP-1 Receptor Agonists

Sessions review the role of GLP-1 therapies in cardiovascular prevention.

Topics Include

• Cardiovascular Outcome Trials
• Weight Reduction
• Glycemic Control
• ASCVD Risk Reduction
• Obesity Management
• Clinical Implementation

Lipid Management

A comprehensive review of dyslipidemia treatment is included.

Covered Topics

• Cholesterol Guidelines
• LDL-C Reduction
• Statin Therapy
• Non-Statin Agents
• Risk-Based Lipid Management
• Hyperlipidemia Treatment Strategies

Participants learn practical approaches to optimizing lipid control in high-risk populations.

Chronic Kidney Disease & Cardiovascular Risk

The curriculum reviews the intersection of cardiovascular and renal disease.

Topics Include

• CKD Risk Assessment
• Cardiorenal Syndrome
• Kidney Protection Strategies
• Diabetes-Related Kidney Disease
• Hypertension & CKD
• Pharmacologic Risk Reduction

High-Risk Patient Populations

Specialized sessions address cardiovascular prevention in complex populations.

Covered Areas

• Older Adults
• Patients with Diabetes
• CKD Patients
• Women’s Cardiovascular Health
• Maternal-Fetal Considerations
• Patients with Established ASCVD

Lifestyle & Non-Pharmacologic Prevention

The program emphasizes comprehensive risk reduction beyond medications.

Topics Include

• Dietary Intervention
• Weight Management
• Physical Activity
• Smoking Cessation
• Behavioral Modification
• Comprehensive Prevention Programs

Why This Course Stands Out

Integrated Cardiometabolic Approach

Combines management of:

• Hypertension
• Diabetes
• Dyslipidemia
• Chronic Kidney Disease
• Cardiovascular Prevention

Strong Focus on Emerging Therapies

Extensive coverage of:

• SGLT2 Inhibitors
• GLP-1 Receptor Agonists
• Modern Preventive Pharmacology

Evidence-Based Curriculum

Built around major clinical trials and contemporary guideline recommendations.

Practical Clinical Application

Focused on real-world implementation in outpatient and preventive cardiology practice.